Post by
tylerreddick on Mar 13, 2024 5:16pm
On the bright side
If, by chance, AbbVie starts promoting a 1067 product at the same time, early next year, when GlycoProtemim hits the market, it could get interesting.
It will likely be a painful 2024 for SBM's downtrodden shareholders, but what if...................?
We have held our noses this long, what's another year, if they actually pull this off? And who really wants to sell at the all-time bottom? Not me, that's for sure.
GLTA, we deserve it.
Comment by
Turtle4 on Mar 14, 2024 7:55am
Next news: PE Partner buys 49% of sirona laboratories for 5 mio$
Comment by
tylerreddick on Mar 14, 2024 8:41am
As long as it isn't 5 bucks!
Comment by
biorun on Mar 14, 2024 12:30pm
I would rather see Sirona take 51% of future sales of $100M than 90% of nothing. If Sirona had a buyout clause that would assert its full ownership rights down the road after everything was paid back plus profit, then even better.
Comment by
tylerreddick on Mar 14, 2024 4:10pm
Well, that made ZERO sense. And check your math while you are at it. And the last time I checked the Canadian dollar was worth less than the US$, not more.